KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Common Equity (2018 - 2025)

Historic Common Equity for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $365.8 million.

  • Aurinia Pharmaceuticals' Common Equity fell 572.96% to $365.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $365.8 million, marking a year-over-year decrease of 572.96%. This contributed to the annual value of $377.5 million for FY2024, which is 12.59% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Common Equity of $365.8 million as of Q3 2025, which was down 572.96% from $335.3 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Common Equity peaked at $479.1 million during Q4 2021, and registered a low of $298.2 million during Q3 2021.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Common Equity value was $378.0 million (recorded in 2023), while the average stood at $382.8 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Common Equity crashed by 2524.08% in 2021 and then surged by 4200.7% in 2022.
  • Aurinia Pharmaceuticals' Common Equity (Quarter) stood at $479.1 million in 2021, then decreased by 15.37% to $405.4 million in 2022, then dropped by 6.78% to $378.0 million in 2023, then fell by 0.13% to $377.5 million in 2024, then fell by 3.1% to $365.8 million in 2025.
  • Its Common Equity was $365.8 million in Q3 2025, compared to $335.3 million in Q2 2025 and $350.2 million in Q1 2025.